Navigation Links
UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims

UCLA investigators reviewed pharmaceutical ads in American medical journals and found that nearly one-third contained no references for medical claims; while the majority of references to published material was available, only a minority of company data-on-file documents were provided upon request; and the majority of original research cited in the ads was funded by or had authors affiliated with the product's manufacturer.

In one of the largest studies of its kind, UCLA investigators reviewed pharmaceutical ads in American medical journals to determine what materials are cited in support of medical claims and if those references are available to physicians. Researchers also determined the funding sources of research cited in the ads.

The study is published in the Feb. 15 issue of the Canadian Medical Association Journal.

"Previous studies have shown that physicians' drug prescribing is influenced by pharmaceutical ads. We wanted to see what documents were being used to substantiate the claims and how accessible these were to physicians who may want to verify the research findings," said lead author Dr. Richelle Cooper, assistant clinical professor, Division of Emergency Medicine, David Geffen School of Medicine at UCLA.

Two UCLA investigators independently reviewed 438 ads from 10 American medical journals from 1999 and also reviewed a random sample of 400 references in journal articles from the same publications for comparison.

Researchers found that out of 438 pharmaceutical ads, 126 (29 percent) offered no references in support of medical claims. The most commonly cited references in the ads included journal articles (55 percent) and data-on-file (19 percent), which is a reference to an unpublished company document. Other sources included books; prescribing information such as the Physician's Desk Reference, which annually provides information on drug usage, warnings and drug interactions; government documents; or an Intern
'"/>

Source:UCLA News


Page: 1 2 3

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
4. Study Links Ebola Outbreaks To Animal Carcasses
5. Breakthrough Microarray-based Technology for the Study of Cancer
6. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
7. Study finds more than one-third of human genome regulated by RNA
8. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
9. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
10. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
11. Study: Soap And Water Work Best In Ridding Hands Of Disease Viruses

Post Your Comments:
(Date:11/19/2009)...he offspring of two inbred strains tend to be supe...gene-level variability that leads to this phenomen...t our ability to custom-tailor crops for specific ...sumption or high glucose content for biomass fuel....ce of the common corn strain B73, University of Mi...
(Date:11/19/2009)...FirstCall/ -- BIO-key International, Inc. (OTC Bul...fety and finger-based biometric identification sol...ting held today was adjourned without any action b... (Logo: http://www.newscom.com/cgi-bin/prnh/20050... the 35 million votes cast voted in favor of the B...
(Date:11/19/2009)...Ming Chu Professor of Biochemistry and Molecular B...ow regulatory proteins control the production of g...g with collaborators including Drs. Mitchell Weiss...lphia, they focused specifically on the complex pr... These cells contain large amounts of hemoglobin, ...
Breaking Biology News(10 mins):U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Carriage Services Announces Third Quarter Earnings Release and Conference Call Schedule 59622 1Carriage Services Announces Third Quarter Earnings Release and Conference Call Schedule 59622 2Carriage Services Announces Third Quarter Earnings Release and Conference Call Schedule 59622 3Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 59620 1Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 59620 2Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 59620 3Atomic Tattoos Announces 26quot 3BTats for Tatas 26quot 3B October Fundraising Event to Benefit Local Breast Cancer Research 59615 1Atomic Tattoos Announces 26quot 3BTats for Tatas 26quot 3B October Fundraising Event to Benefit Local Breast Cancer Research 59615 2
... new book, distinguished geneticist and historian ...w of human nature, one that is based on our biolog...and evolution. , , [M]ost of humanity has an out... is better suited for living in the first or secon... book, which is entitled Neither Gods Nor Beasts:...
...erine scat samples collected on the Tahoe National...wolverine populations, according to U.S. Forest Se...Rocky Mountain Research Station recently began ana...Tahoe National Forest and California Department of... they collected from wolverine detection sites on ...
...ational leader in the use of lifesaving ventricula...ure is part of a collaboration that recently has ...l Institutes of Health (NIH) to develop an externa...ren. , VADs are mechanical devices that take over...ing support, most often acting as a bridge to keep...
Other Biology News:A call to infuse scientific knowledge into the human experience 2Preliminary DNA analysis completed on California wolverine 2Children's Hospital leads projects to develop nation's first heart assist devices for young children 2Children's Hospital leads projects to develop nation's first heart assist devices for young children 3
(Date:11/18/2009)...tute of Standards and Technology (NIST) has demons... detecting and measuring elusive hazards such as c... in food or pesticides distributed in soil by wind...than conventional techniques for detecting traces ...cules, having distinct electrically positive and n...
(Date:11/18/2009).... 18 Sangamo BioSciences...from the University of Pennsylvania investigator s...nger nuclease (ZFN) based product, SB-728-T, for H...ed on the internet. ,, Data were presented in a...School of Medicine from a single subject treated w...
(Date:11/18/2009)... Reportlinker.com announces that a...talogue. ,, Biotechnology Reagents - A Global...ker.com/p0164375/Biotechnology-Reagents---A-Global...;utm_medium=pr&utm_campaign=prnewswire ,,...al compounds used in a range of biotech related ar...
(Date:11/18/2009)...reduces key cardiac enzymes at multiple time point...n Heart Association 2009 Scientific Sessions ,,...utics Inc., a biotechnology company pioneering the...tics derived from pathogens, today reported result...1 (Serp-1), an anti-inflammatory protein derived f...
Breaking Biology Technology:Prototype NIST method detects and measures elusive hazards 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4
...ept. 27 Cattle producers,soon will find that the ...ood supply safe are as close at hand as their desk...University is leading to the creation of,software ...e Sanderson,associate professor of production medi...is involved in research that will help producers,m...
...t. 27 Mediatech, Inc. is settling,into their bran... of land,in Prince William County. Right down the ...r for Biodefense, Mediatech joins other,biotechnol...novation Park. (Photo: http://www.newscom.com/cg...facturing plant has been a work in progress since,...
...s Amended the Design of the Ofatumumab Pivotal Stu...in,s lymphoma and Reduced the Numb...eptember 27 Genmab A/S (OMX:,GEN) announced today...tudy,of ofatumumab (HuMax-CD20(R)) in rituximab re...o a single arm trial that will now include,approxi...
Other Biology Technology:K-State Research Leading to Software to Help Nation's Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online 2Mediatech Moves to Prince William County Innovation Park 2Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study 2Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study 3
Skirted Tubes, 2.0 ml, nonsterile, separate screwcaps, 500 from Bio-Rad
Mouse Anti-Human Caspr2 Monoclonal Antibody, Unconjugated, Clone K67/25 from UC Davis/NINDS/NIMH NeuroMab Facility
... new line of Protein Standards, a growing family o...ectrometry, molecular biology, and life science la...ality purified proteins for use in the calibration...ss spectrometry (ESI-MS). For quality control and...
PIP Microstrips from Echelon Biosciences Inc.
Biology Products: